Mouse IgG1 kappa, Isotype Control
Based on 8 publication(s) in Google Scholar
Mouse IgG1 kappa, Isotype Control is a negative control reagent/isotype control for mouse-derived IgG1κ antibodies. Mouse IgG1 kappa, Isotype Control, by maintaining the same immunoglobulin structure (including isotype, light chain, etc.) as the specific mouse IgG1κ subtype primary antibody, eliminates false positive signals caused by non-specific binding in immunological experiments, thus playing a core role in verifying the specificity of the experiment. Mouse IgG1 kappa, Isotype Control can be applied to immunolocalization experiments in the field of cell biology, such as immunofluorescence staining and immunohistochemistry, assisting in research on protein subcellular localization and cell structure analysis, ensuring the reliability of experimental results.
For research use only. We do not sell to patients.
- Purity: 99.36%
- Molecular Weight:145.06 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Mouse IgG1 kappa, Isotype Control
More- Immunity. 2024 Jul 23:S1074-7613(24)00351-0. [Abstract]
- Drug Resist Updat. 2026 Feb 8;86:101375.
- Drug Resist Updat. 2026 Feb 8:86:101375. [Abstract]
- Cell Mol Immunol. 2025 Jan;22(1):83-96. [Abstract]
- Leukemia. 2025 Aug 15. [Abstract]
- Int Immunopharmacol. 2025 Aug 26:164:115421. [Abstract]
- Int Immunopharmacol. 2025 May 29:160:114906. [Abstract]
- Neuropharmacology. 2026 Jun 1:290:110908. [Abstract]
-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
RT-PCR
Biological Activity
Mouse IgG1 kappa Isotype Control is primarily used as a negative control in immunofluorescence staining experiments. When using mouse IgG1 subtype monoclonal antibodies for protein localization studies, it helps eliminate interference from non-specific antibody binding, allowing researchers to determine whether the staining signal of the target antibody is due to specific binding with the antigen, thus providing a basis for the specificity and reliability of the experimental results[1].
It is especially suitable for experimental scenarios involving simultaneous immunolocalization with two different subtypes of mouse monoclonal antibodies (such as IgG1 and IgG1)[1].
Applicable Features
1. No specific target, does not specifically bind to the target antigen in the experiment, only provides a background baseline for non-specific binding[1].
2. Subtype-specific matching: It must match the target primary antibody (mouse IgG1 subtype) used in the experiment to accurately eliminate subtype-related non-specific binding interference[1].
3. Does not possess biological activity such as agonism or inhibition; it only serves as an experimental control tool and does not affect the structure and function of the cells themselves[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Appearance Liquid
-
Molecular Weight 145.06 kDa
-
Color Colorless to light yellow
-
SMILES
[Mouse IgG1 kappa, Isotype Control]
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (8)
-
Journal Impact Factor
-
Most Recent
-
Immunity
Brain ischemia causes systemic Notch1 activity in endothelial cells to drive atherosclerosis. [Abstract]2024 Jul 23:S1074-7613(24)00351-0. PMID: 39079536
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Immunity. 2024 Jul 23:S1074-7613(24)00351-0. [Abstract]
HUVECs were pretreated with IgG (Mouse IgG1 kappa, Isotype Control) or anti-Notch1 antibodies at 10 μg/mL for 2 h, then given control exosomes or stroke exosomes (15 μg/mL) for 24 h. mRNA expression of Notch1, VCAM1, P16, and P53 were assessed by quantitative real-time PCR. n = 6 per group.
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Immunity. 2024 Jul 23:S1074-7613(24)00351-0. [Abstract]
HUVECs were pretreated with IgG (Mouse IgG1 kappa, Isotype Control) or anti-Notch1 antibodies at 10 μg/mL for 2 h, then given control exosomes or stroke exosomes (15 μg/mL) for 24 h. Flow cytometry analysis of Notch1, VCAM1, P16, and P53 expression in HUVECs.
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Immunity. 2024 Jul 23:S1074-7613(24)00351-0. [Abstract]
HUVECs were pretreated with IgG (Mouse IgG1 kappa, Isotype Control) or anti-Notch1 mAb at 10 μg/mL for 2 h, then given control exosomes or stroke exosomes (15 μg/mL) for 24 h. THP-1 cells were labeled with fluorescence dye, then cell adhesion assay was performed. Representative images of adhesive cells.
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Immunity. 2024 Jul 23:S1074-7613(24)00351-0. [Abstract]
Wild-type mice received intraperitoneal (i.p.) injections of IgG control (Mouse IgG1 kappa, Isotype Control ) or anti-VCAM1 mAb (5 mg/kg/week) following MCAO surgery. Flow cytometry analysis was conducted at day 14 after surgery. Counts of Ly6Chigh monocytes (left) and neutrophils (right) in aorta. n = 6 mice per group. Data were representative of three independent experiments.
-
-
Drug Resist Updat
RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress. [Abstract]2026 Feb 8:86:101375. PMID: 41687462 -
Cell Mol Immunol
2025 Jan;22(1):83-96. PMID: 39627610
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Cell Mol Immunol. 2025 Jan;22(1):83-96. [Abstract]
Schematic diagram of the application of 4-OHT to the ears of HO (Ppargfl/fl;Krt5creERT2/+) mice for 5 consecutive days, along with intradermal injections of neutralizing antibodies to IFNAR (HY-P99137; Anti-Mouse IFNAR1 Antibody (MAR1-5A3)) or anti-mouse IgG1 isotype controls (HY-P99977; Mouse IgG1 kappa, Isotype Control) on days 3 and 7 (intradermally administered 40 μl of a 2 mg/ml solution). Quantification and qualification of urine protein.
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Cell Mol Immunol. 2025 Jan;22(1):83-96. [Abstract]
Schematic diagram of the application of 4-OHT to the ears of HO (Ppargfl/fl;Krt5creERT2/+) mice for 5 consecutive days, along with intradermal injections of neutralizing antibodies to IFNAR (HY-P99137; Anti-Mouse IFNAR1 Antibody (MAR1-5A3)) or anti-mouse IgG1 isotype controls (HY-P99977; Mouse IgG1 kappa, Isotype Control) on days 3 and 7 (intradermally administered 40 μl of a 2 mg/ml solution). The levels of anti-double-stranded DNA antibodies and antinuclear antibodies in the peripheral blood of the mice on day 17.
-
Leukemia
Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment. [Abstract]2025 Aug 15. PMID: 40817406
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Leukemia. 2025 Aug 15. [Abstract]
Effect of cytokine signaling blockade on ALL cell survival in co-culture with stromal populations. ALL cells were co-cultured with early mesenchymal progenitors, adipogenic progenitors, or cultured alone. Cell survival was assessed after treatment with blocking antibodies against IL7, Osteopontin, or the CXCR4 inhibitor Plerixafor (1 nM; 7 days), Mouse IgG1 kappa, Isotype Control (1 ug/mL; 7 days).
Mouse IgG1 kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Leukemia. 2025 Aug 15. [Abstract]
Effect of cytokine signaling blockade on ALL cell survival in co-culture with stromal populations. ALL cells were co-cultured with early mesenchymal progenitors, adipogenic progenitors, or cultured alone. Effect of VCAM1 blockade on ALL cell viability in co-culture or monoculture. Effect of blocking integrin beta 1 (ITGB1) using a blocking antibody or the small peptidomimetic drug BIO-1211 (50 uM; 7 days), Mouse IgG1 kappa, Isotype Control (1 ug/mL; 7 days)on ALL cell viability in co-culture or monoculture.
-
Int Immunopharmacol
Intratumoral microbiota-driven macrophage reprogramming in pancreatic cancer via Blautia metabolite 6-hydroxyhexanoic acid. [Abstract]2025 Aug 26:164:115421. PMID: 40865404 -
Int Immunopharmacol
Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer. [Abstract]2025 May 29:160:114906. PMID: 40446696 -
Neuropharmacology
Anxiety in male psoriasis mouse model is mediated by the interaction between γδ T cell-derived IL-17A and microglia. [Abstract]2026 Jun 1:290:110908. PMID: 41780818
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Donaldson JG, et al. Immunofluorescence Staining. Curr Protoc Cell Biol. 2015 Dec 1;69:4.3.1-4.3.7. [Content Brief]
[2]. Song JS, et al. Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen. Blood. 2004 Oct 1;104(7):2065-72. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)